Therefore, ALK− ALCL should be distinguished from conditions like primary cutaneous ALCL (C-ALCL), various subtypes of CD30+ T-cell or B-cell lymphoma subtypes exhibiting anaplastic features, or classic Hodgkin lymphoma (CHL). This evidence concerns the gene TNFRSF8 and B-cell non-Hodgkin lymphoma.